Insider trade

Lifeward (LFWD): Chief Medical Officer received 15K shares

Keith Dale Rose, Chief Medical Officer at Lifeward, reported a grant / award of 15K shares.

15K
Shares
Traded
May 1, 2026
Filed
May 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 24, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year
  2. Mar 17, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On March 17, 2026, Lifeward Ltd. (the “Company”) received a notice (the “Audit Committee Notice”) from the Nasdaq Listing Qualifications Department indicating that, following Hadar Levy’s resignation from the Board of Directors of the Company, which reduced the Audit Committee to two members, the Company no longer complies with the audit committee requirement under Nasdaq Listing Rule 5605(c)(2)(A), which requires…”
  3. Mar 18, 2026Company filing · Form 8-K · ResultsReported its results
  4. Mar 25, 2026Company filing · Form 8-K · Acquisition or sale, Unregistered sharesCompleted buying or selling a business or assets, and changed a top executive or board member (and 1 more item)“On March 25, 2026, Dr. John William Poduska and Randel Richner, current Class II directors of the Board of Directors (the “Board”) of the Company notified the Board of their decision to step down from the Board, effective as of March 25, 2026.”
  5. Apr 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers’ Compensatory Arrangements of Certain Officers. Pursuant to notice provided on April 20, 2026, Jeannine Lynch’s employment with Lifeward Ltd. (the “Company”) as the Vice President of Strategy and Market Access will be terminated, effective May 3, 2026.”

What came next

  1. May 15, 2026Company filing · Form 8-K · ResultsReported its results
  2. Jun 30, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
  3. Aug 10, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On August 12, 2026, each of Robert J. Marshall, Jr., Michael Swinford and William Mark Sigsbee notified the Board of their decision to step down from the Board, effective as of August 13, 2026.”
  4. Aug 14, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 14, 2026, the Board of Directors (the “Board”) of Lifeward Ltd. (the “Company”) appointed Yonason Greenwald and Haggai Zamir, each to serve as a Class III Director, with an initial term expiring at the Company’s 2026 Annual Meeting of Shareholders.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Lifeward

OQRO holds no insider, Congress, fund or contract record for Lifeward dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LFWD page.

How this filing works

Explore the data

Common questions

Which Lifeward (LFWD) insider traded, and how much?

Keith Dale Rose, Chief Medical Officer at Lifeward, reported a grant / award of 15K shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: May 1, 2026. Filed: May 20, 2026. That is 19 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean LFWD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Lifeward

Everything OQRO holds on this company is on its LFWD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data